Psoriatic Arthritis

Latest News

Psoriasis and Psoriatic Arthritis Linked to Depression and Functional Impairment
Psoriasis and Psoriatic Arthritis Linked to Depression and Functional Impairment

November 29th 2023

Depression, functional impairment, and worsened quality of life are related in patients with psoriatic disease, according to a recent study.

TAK-279 Shows Significant Efficacy in Phase 2b Psoriatic Arthritis Study
TAK-279 Shows Significant Efficacy in Phase 2b Psoriatic Arthritis Study

November 7th 2023

FDA Approves Ustekinumab-auub as Interchangeable Biosimilar to Stelara for Plaque Psoriasis, Psoriatic Arthritis, and More
FDA Approves Ustekinumab-auub as Interchangeable Biosimilar to Stelara for Plaque Psoriasis, Psoriatic Arthritis, and More

November 1st 2023

Amgen to Present New MOSAIC Phase 4 Data at EULAR 2023
Amgen to Present New MOSAIC Phase 4 Data at EULAR 2023

June 1st 2023

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial
Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

May 31st 2023

Video Interviews
Podcasts
The Cutaneous Connection
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

More News

© 2023 MJH Life Sciences

All rights reserved.